COVERA-HS Drug Patent Profile
✉ Email this page to a colleague
When do Covera-hs patents expire, and when can generic versions of Covera-hs launch?
Covera-hs is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in COVERA-HS is verapamil hydrochloride. There are seventeen drug master file entries for this compound. Forty-four suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Covera-hs
A generic version of COVERA-HS was approved as verapamil hydrochloride by EXELA PHARMA on March 30th, 1984.
Summary for COVERA-HS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 78 |
Clinical Trials: | 4 |
Formulation / Manufacturing: | see details |
DailyMed Link: | COVERA-HS at DailyMed |
Recent Clinical Trials for COVERA-HS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Assiut University | Early Phase 1 |
Ann & Robert H Lurie Children's Hospital of Chicago | Phase 2 |
Mayo Clinic | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for COVERA-HS
US Patents and Regulatory Information for COVERA-HS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | COVERA-HS | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020552-001 | Feb 26, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | COVERA-HS | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020552-002 | Feb 26, 1996 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for COVERA-HS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Pfizer | COVERA-HS | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020552-001 | Feb 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | COVERA-HS | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020552-001 | Feb 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | COVERA-HS | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020552-002 | Feb 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | COVERA-HS | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020552-002 | Feb 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | COVERA-HS | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020552-001 | Feb 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
Pfizer | COVERA-HS | verapamil hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 020552-001 | Feb 26, 1996 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for COVERA-HS
See the table below for patents covering COVERA-HS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Austria | 210429 | ⤷ Try a Trial | |
European Patent Office | 0591389 | FORME DE DOSAGE POUR LIBERATION RETARDEE DE MEDICAMENT (DOSAGE FORM FOR A DELAYED DRUG DELIVERY) | ⤷ Try a Trial |
Ireland | 840010 | ⤷ Try a Trial | |
Austria | 394944 | ⤷ Try a Trial | |
European Patent Office | 0052917 | OSMOTIC DEVICE WITH HYDROGEL DRIVING MEMBER | ⤷ Try a Trial |
Portugal | 88618 | APERFEICOAMENTOS NA FORMA DE DOSAGEM E DISPOSITIVO OSMOTICOS PARA O TRATAMENTO DE DOENCAS CARDIOVASCULARES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |